Expert Panel Discussion and Q&A - July 23, 2022
- Non-Member - $39
- Regular Member - $29
- Retired - $29
- Early Career Physician - $29
- Resident - $19
- Student - $19
- Associate - $19
- ASAM Staff - Free!
- International Member - $29
- Emeritus Member - $29
- Provisional Member - $29
- Fellow Member - $29
- Honorary Member - $29
- CRT Member - $29
Expert Panel Discussion and Q&A - July 23, 2022
Recorded: Friday, July 22, 2022 - Sunday, July 24, 2022
This 60-minute, on-demand session from the ASAM 2022 Review Course provides answers to the top questions asked during Faculty presentations covering Epidemiology, Ethics and the Law, Psychiatric Co-Morbidities, and Prevention and Public Health.
This panel session will provide a prime opportunity for learners to get their questions answered on topics that were presented on day two of the ASAM Review Course. Session Topics Being Discussed: -Behavioral Addiction: From Theory to Treatment -Epidemiology: Core Concepts and Applications -Ethics and the Law: Principles and Treatment Implications -Psychiatric Co-Morbidities: Assessment and Treatment -Prevention and Public Health: Principles and Applications -Medical Co-Morbidities: Prevention and Treatment -Pharmacology and Toxicology: Principles, Applications and Limitations
The target audience for this introductory and intermediate level activity includes: Physicians preparing for the ABPM or AOA Board Certification Examination in addiction medicine, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.
This activity addresses the following ACGME Competencies: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement
Upon completion, learners will be able to:
- Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
- Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
- Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
- Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
- Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse
|ASAM Learner Type||Rate|
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Deadline: 08/15/2025
- Click on the Contents tab to begin this activity.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Jonathan Avery (Moderator)
Jonathan Avery, MD is currently the Director of Addiction Psychiatry and an Associate Professor of Clinical Psychiatry at Weill Cornell Medical College and New York-Presbyterian Hospital. In addition to his clinical work, Dr. Avery teaches addiction psychiatry to the Weill Cornell medical students and residents of New York-Presbyterian Hospital. He has been published on a broad variety of topics in psychiatry, including papers on subjects ranging from clinician attitudes towards patients to how to use buprenorphine. He is the founder of the Addiction Stigma Institute that studies stigma towards individuals with substance use disorders and creates novel interventions to improve these stigmatizing attitudes. He was on the editorial board for the DSM-5 Clinical Cases book and is the editor of the books Co-occurring Mental Illness and Substance Use Disorders: A Guide to Diagnosis and Treatment and The Stigma of Addiction: An Essential Guide. He has won numerous awards for his clinical and academic work, including the American Board of Psychiatry and Neurology Faculty Innovation in Education Award and the Outstanding Faculty Member Award from the New York County Psychiatric Society.
No Relevant Financial Disclosures
Faye Chao, MD is the unit chief of the inpatient addiction services at Mount Sinai West Hospital. She attended Jefferson Medical College in Philadelphia and completed her general psychiatry residency training at Harvard Longwood. She went on to an addiction psychiatry fellowship at NYU, and after fellowship, she worked at Bellevue Hospital for 1.5 years before moving on to her current position. She is board certified in both General and Addiction Psychiatry. Within the field of psychiatry, her interests include internet addiction and the management of pain in the addicted population.
Jeffrey DeVido, MD, MTS, FASAM, FAPA
Chief, Addiction Services//Behavioral Health Clinical Director
Marin County CA Dept of HHS//Partnership HealthPlan of CA
Jeffrey DeVido, MD, MTS, FASAM, FAPA is board certified in General Psychiatry, Addiction Psychiatry, and Addiction Medicine and works in Northern California. Upon completion of residency and fellowship training at Massachusetts General and McLean Hospitals/Partners Healthcare, he attended on the psychaitric consultation-liaison service at UCSF, Parnassus Campus for 3 years. For the past 5 years, Dr. DeVido has been Chief of Addiction Services with Marin County, CA, Department of Health and Human Services and Behavioral Health Clinical Director with Partnership HealthPlan of CA. In both of these roles, he is involved in managing the development of substance use and co-occurring services for Medicaid beneficiaries in 14 counties between the Oregon border and San Francisco. In his free time, he enjoys fly fishing, chasing around his 3 young kids, watercolor painting, Philadelphia sports, and Star Trek.
Nature of Relevant Financial Disclosure: Philip Morris/Altria: Equity Shareholder, from inheritance and Merck: Equity Shareholder, from inheritance
H. Westley Clark, MD, JD, MPH, DFASAM
Dean's Executive Professor of Public Health
Santa Clara University
H. Westley Clark, MD, JD, MPH is currently the Dean’s Executive Professor of Public Health at Santa Clara University in Santa Clara California. He is formerly the Director of the Center for Substance Abuse Treatment, SAMHSA, U.S. Department of Health and Human Service.
He contributed to the US Surgeon General’s Report on Alcohol, Drug Abuse and Health as a Section Editor for Treatment. He is on the National Advisorry Council of NIAAA. He has served on the National Advisory Council of NIDA. He was a member of the Board of Directors of the non-profit Felton Institute, He was on the Board of Directors of Faces and Voices of Recovery. He was also on the Board of Directors of the Pacific Institute for Research and Evaluation.
He has received numerous awards for his contributions to the field of substance abuse treatment, including: the 2015 Lisa Mojer-Torres Award from Faces and Voices of Recovery, the 2015 James Ralph Memorial Award for Outstanding Public Service from the Black Psychiatrist of America, A 2015 Annual Award, American Society of Addiction Medicine. He was awarded the 2008 John P. McGovern Award from the American Society of Addiction Medicine.
Dr. Clark received a B.A. in Chemistry from Wayne State University; he holds a MD and a MPH from the University of Michigan; where he completed a Psychiatric Residency at University Hospital, Neuropsychiatric Institute. He obtained his Juris Doctorate from Harvard University Law School and completed a two-year Substance Abuse Fellowship at the DVAMC-SF. Dr. Clark received his board certification from the American Board of Psychiatry and Neurology in Psychiatry. He is a Distinguished Fellow of the American Society of Addiction Medicine. He is certified in Addiction Medicine by the American Board of Preventive Medicine. Dr. Clark is licensed to practice medicine in California, Maryland, Massachusetts and Michigan. He is also a member of the Washington, D.C., Bar.
Kelly Kleinert, MD is an Assistant Clinical Professor of Psychiatry at Columbia University Vagelos College of Physicians and Surgeons, board-certified in Psychiatry and Addiction Medicine. She is Associate Unit Director on 4 South, the inpatient unit of the Washington Heights Community Service at New York State Psychiatric Institute, where she works with patients with severe mental illness and often concomitant substance use disorders. Previously, she worked at Janian Medical Care, a nonprofit psychiatric and primary medical care organization in New York City, caring for individuals with co-occurring psychiatric and substance use disorders on a homeless outreach team and on an Assertive Community Treatment (ACT) team. Dr. Kleinert graduated from Columbia University Vagelos College of Physician and Surgeons and completed residency in General Psychiatry at New York University/Bellevue Hospital. Following residency, she returned to Columbia to complete a fellowship in Public Psychiatry.
Amesika Nyaku, MD MS is an Assistant Professor at Rutgers New Jersey Medical, Department of Medicine, Division of Infectious Diseases. She completed her medical training at Northwestern University and remained there for Internal Medicine residency and Infectious Diseases fellowship. She provides clinical care for people living with HIV as well as for people with general infectious diseases. Her research interests currently focus on improving antiretroviral therapies and improving HIV care for vulnerable populations. She is an investigator on the AIDS Clinical Trials Group’s Antiretroviral Therapy Strategies Transformative Science Group which is tasked with evaluating new HIV treatment strategies. She is also co-director of the Northern New Jersey Medication-Assisted Treatment Center of Excellence and the emphasis of her work is the development of clinical programs for people living with HIV and opioid dependence that lead to improvements in HIV viral load suppression.
Annie Levesque, MD, MSc is the Medical Director of the Opioid Treatment Program at the Addiction Institute at Mount Sinai West. She is also the Associate Director of the Fellowship in Addiction Medicine Program at the Icahn School of Medicine at Mount Sinai. After receiving her medical degree from the University of Montreal, Dr. Levesque completed a Family Medicine and a Clinician-Scholar residency program at the University of Montreal, an Addiction Medicine fellowship at Mount Sinai West Hospital and a Masters in Experimental Medicine at McGill University
MD, FACEP, FACMT, FASAM
Lewis Nelson, MD, FACEP, FACMT, FASAM is Professor and Chair of the Department of Emergency Medicine and Chief of the Division of Medical Toxicology at Rutgers New Jersey Medical School in Newark, NJ. He is a member of the Board of Directors of the American Board of Emergency Medicine and a Past-President of the American College of Medical Toxicology. He remains actively involved with the CDC, FDA, DHS, and several professional medical organizations, including ASAM. Dr. Nelson is an editor of the textbook Goldfrank’s Toxicologic Emergencies and on the editorial boards of several journal.
CME, CE, CEU and Other Credit Types
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Maintenance of Certification
The American Board of Medical Specialties (ABMS)
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory ASAM Review Course in Addiction Medicine has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: Allergy and Immunology, Anesthesiology, Family Medicine, Physical Medicine and Rehabilitation, Psychiatry and Neurology, Preventive Medicine, Radiology.
American Board of Preventive Medicine (ABPM)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.
American Board of Anesthesiology (ABA)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.
American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.
American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit
American Board of Psychiatry and Neurology (ABPN)
Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.
Royal College of Physicians and Surgeons of Canada (RCPSC)
Royal College Fellows can use participation in Accredited Continuing Medical Education to earn Section 3 Credits
American Board of Addiction Medicine (ABAM)
Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
|Access Date||Quiz Result||Score||Actions|